Latest / Durham News Today | 2 Min News | The Daily News Now!
Guardant Health Soars on UnitedHealth Deal | Durham News
Guardant Health just got a massive boost as Bernstein raised its stock price target to $200, keeping an “Outperform” rating — fueled by UnitedHealth’s surprise decision to cover Guardant’s Shield test for millions of older members, sending the stock up nearly 20% and hitting its highest point in a year. Beyond this game-changing move, the company also landed FDA approval for an expanded test, got added to the American Cancer Society’s screening guidelines, and joined the Russell 1000 — all while facing headwinds like potential overvaluation, insider selling, and stiff competition. Listen in…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.